<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Acute rheumatic fever is an illness caused by an immunological reaction to group A streptococcal infection of the throat. The onset of symptoms occurs 1-3 weeks after an untreated or inadequately treated throat infection. The disease occurs mainly in children and adolescents with a peak age of 5-15 years. Acute rheumatic fever often results in lasting damage to heart valves leading to the chronic form, which is known as rheumatic heart disease.</span></p><p style="text-align:justify;"><span >Individuals who have had acute rheumatic fever previously are more likely to have subsequent episodes. These recurrences may cause further heart valve damage. Following treatment of an acute episode, secondary prophylaxis should be continued for a minimum of 10 years after the recent episode of acute rheumatic fever or until age 21 years (whichever is longer). For those with severe rheumatic heart disease secondary prophylaxis should be continued indefinitely.</span></p><p style="text-align:justify;"><span >Rheumatic heart disease is an important cause of heart failure and premature death. In Ghana, acute rheumatic fever may mimic malaria, typhoid fever and other febrile conditions, while the joint symptoms may mimic sickle cell disease.</span></p><p style="text-align:justify;"><span >Jones criteria is used for diagnosis of rheumatic fever.</span></p><p style="text-align:justify;"> </p><h3>CAUSES</h3><p> • Group A streptococcal infection</p><h3>SYMPTOMS</h3><p> • Fever</p><p> • Malaise</p><p> • Joint pain which moves from one joint to another (knees, ankles, wrists, elbows)</p><p> • Palpitations</p><p> • Easy fatiguability</p><p> • Chest pain</p><p> • Skin rash</p><p> • Abnormal body movements (chorea)</p><h3>SIGNS</h3><p> • Fever &gt; 38°C (minor criteria)</p><p> • Single joint tenderness and or swelling (minor criteria)</p><p> • Rapid heart rate ( &gt; 100/minute), murmur, heart failure, pericardial rub (suggests carditis) (major criteria)</p><p> • Skin rash</p><p> • Subcutaneous nodules over bony prominences</p><h3>INVESTIGATIONS</h3><p> • FBC</p><p> • ESR &gt; 30 or C-reactive protein&gt; 3 mg/dL (minor criteria)</p><p> • Sickling status</p><p> • Chest X-ray</p><p> • Throat swab for culture</p><p> • Anti-streptolysin O titre</p><p> • 12-lead ECG (prolonged PR interval for age - minor criteria)</p><p> • Echocardiogram evidence of carditis (major criteria)</p><p> </p><h3>Treatment objectives</h3><ul><li>To eradicate streptococcal throat infection</li><li>To suppress inflammatory response</li><li>To prevent recurrent episodes of rheumatic fever and further heart valve damage</li><li>To treat heart failure if co-existent</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Bed rest</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A. Treatment of Acute Rheumatic Fever</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p><span ><strong> Evidence Rating: [C]</strong></span></p><ul><li>Benzathine benzylpenicillin, IM,</li></ul><p>2" 30 kg body weight; 1,200,000 U as a single dose</p><p>&lt; 30 kg body weight;  600,000 U as a single dose</p><h3>Or</h3><ul><li>Phenoxymethyl penicillin (Penicillin V), oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 12 hourly for 10 days</p><p><strong><u>Children</u></strong></p><p>6-12years;250 mg 12 hourly for 10 days</p><p>1-5 years;  125 mg 12 hourly for 10 days</p><h3>Or</h3><ul><li>Erythromycin, oral, (for patients allergic to penicillin)</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 12 hourly for 10 days</p><p><u>Children</u></p><p>8-12 years;500 mg 12 hourly for 10 days</p><p>3-8 years;250 mg 12 hourly for 10 days</p><p>1-2 years;125 mg 12 hourly for 10 days</p><h3>And</h3><p><span ><strong>Evidence Rating: [B]</strong></span></p><ul><li>Aspirin, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>300-900 mg 4-6 hourly until joint symptoms relieved, and gradually withdraw over 1-2 weeks.</p><p><strong><u>Children</u></strong></p><p>1 month-18 years; 25 mg/kg 6 hourly until joint symptoms relieved, and gradually withdraw over 1-2 weeks.</p><h3>Or</h3><p><span ><strong>Evidence Rating: [B]</strong></span></p><ul><li>Ibuprofen, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>200-800 mg 6-8 hourly (max. 2400 mg daily)</p><p><strong><u>Children</u></strong></p><p>10-15 mg/kg 6-8 hourly (max. 40 mg per kg daily)</p><p><span ><strong>B. Treatment of Acute Rheumatic Fever with Carditis</strong></span></p><p><span >As in 'treatment option A' above</span></p><h3>And</h3><ul><li>Prednisolone, oral,</li></ul><p><strong><u>Adults</u> and <u>Children</u></strong></p><p>2 mg/kg daily for 2 weeks and then gradually taper off by 20-25% per week for 1-3 weeks.</p><p><span ><strong>C. Treatment of Acute Rheumatic Fever with Heart Failure</strong></span></p><p><span >As in 'treatment option A' above</span></p><h3>And</h3><p><span >Treatment for heart failure (See section on 'Heart failure')</span></p><p><span ><strong>D. Secondary prevention (prophylaxis) of acute rheumatic fever and rheumatic heart disease</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><ul><li>Benzathine benzylpenicillin, IM,</li></ul><p>2" 30 kg body weight;  1,200,000 U</p><p>&lt; 30 kg body weight;  450 mg (600,000 U) 4-weekly</p><p><span ><strong>2<sup>nd</sup> Line Treatment</strong></span></p><ul><li>Phenoxymethyl penicillin (Penicillin V), oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 12 hourly daily</p><p><strong><u>Children</u></strong></p><p>6-12years;  250 mg 12 hourly</p><p>1-5 years;  125 mg 12 hourly</p><h3>Or</h3><ul><li>Erythromycin, oral, (for patients allergic to penicillin)</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 12 hourly</p><p><strong><u>Children</u></strong></p><p>8-12 years; 500 mg 12 hourly</p><p>3-8 years;  250 mg 12 hourly</p><p>1-2 years; 125 mg 12 hourly</p><h3>REFERRAL CRITERIA</h3><p><span >Refer all patients to a paediatrician, physician specialist or cardiologist as necessary for further management</span></p>
</body>
</html>
